Screener
Pasithea Therapeutics KTTA Q4 2026 earnings
Reported February 25, 2026
EPS-$0.18In line
Revenue estimate$200.0K
EPS estimate-$0.18
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Pasithea Therapeutics report Q4 2026 earnings?
- Pasithea Therapeutics (KTTA) reported Q4 2026 earnings on February 25, 2026.
- What were Pasithea Therapeutics's Q4 2026 revenue and EPS?
- Pasithea Therapeutics reported eps of $-0.18 for Q4 2026.
- Did Pasithea Therapeutics beat estimates in Q4 2026?
- EPS beat the consensus estimate of $-0.18 by $0.00.
- How did Pasithea Therapeutics's Q4 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 79.8% from $-0.89.
